Comments to "Fluvoxamine and long COVID-19: a new role for sigma-1 receptor (S1R) agonists" by Khani and Entezari-Maleki.
作者信息
Hashimoto Yaeko, Suzuki Takuji, Hashimoto Kenji
机构信息
Department of Respirology, Chiba University Graduate School of Medicine, Chiba, 260-8670, Japan.
Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, 260-8670, Japan.
出版信息
Mol Psychiatry. 2022 Sep;27(9):3563-3564. doi: 10.1038/s41380-022-01546-2. Epub 2022 Apr 6.
Abstract
摘要
相似文献
1
Comments to "Fluvoxamine and long COVID-19: a new role for sigma-1 receptor (S1R) agonists" by Khani and Entezari-Maleki.对哈尼和恩特扎里 - 马莱基所著《氟伏沙明与长新冠：西格玛 - 1受体（S1R）激动剂的新作用》的评论
Mol Psychiatry. 2022 Sep;27(9):3563-3564. doi: 10.1038/s41380-022-01546-2. Epub 2022 Apr 6.
2
Fluvoxamine and long COVID-19; a new role for sigma-1 receptor (S1R) agonists.氟伏沙明与长期新冠；σ-1受体（S1R）激动剂的新作用
Mol Psychiatry. 2022 Sep;27(9):3562. doi: 10.1038/s41380-022-01545-3. Epub 2022 Apr 6.
3
Homozygosity for rs17775810 Minor Allele Associated With Reduced Mortality of COVID-19 in the UK Biobank Cohort.英国生物库队列中 rs17775810 次要等位基因纯合与 COVID-19 死亡率降低相关。
In Vivo. 2021 Mar-Apr;35(2):965-968. doi: 10.21873/invivo.12338.
4
Fluvoxamine and long COVID: Post-acute recovery.氟伏沙明与长期新冠：急性后期恢复
Rev Med Virol. 2024 Jul;34(4):e2557. doi: 10.1002/rmv.2557.
5
Sigma-1 receptor modulation by fluvoxamine ameliorates valproic acid-induced autistic behavior in rats: Involvement of chronic ER stress modulation, enhanced autophagy and M1/M2 microglia polarization.氟伏沙明对西格玛-1受体的调节改善了丙戊酸诱导的大鼠自闭症行为：涉及慢性内质网应激调节、增强自噬以及M1/M2小胶质细胞极化。
Prog Neuropsychopharmacol Biol Psychiatry. 2025 Jan 10;136:111192. doi: 10.1016/j.pnpbp.2024.111192. Epub 2024 Nov 5.
6
The role of sigma-1 receptor and brain-derived neurotrophic factor in the development of diabetes and comorbid depression in streptozotocin-induced diabetic rats.σ-1受体和脑源性神经营养因子在链脲佐菌素诱导的糖尿病大鼠糖尿病及共病抑郁发生中的作用
Psychopharmacology (Berl). 2016 Apr;233(7):1269-78. doi: 10.1007/s00213-016-4209-x. Epub 2016 Jan 26.
7
Sigma-1 Receptor (S1R) Interaction with Cholesterol: Mechanisms of S1R Activation and Its Role in Neurodegenerative Diseases.Sigma-1 受体（S1R）与胆固醇的相互作用：S1R 激活的机制及其在神经退行性疾病中的作用。
Int J Mol Sci. 2021 Apr 15;22(8):4082. doi: 10.3390/ijms22084082.
8
Sigma-1 Receptor as a Novel Therapeutic Target in Diabetic Kidney Disease.西格玛-1受体作为糖尿病肾病的新型治疗靶点
Int J Mol Sci. 2024 Dec 12;25(24):13327. doi: 10.3390/ijms252413327.
9
Short-chain fatty acids mitigate Methamphetamine-induced hepatic injuries in a Sigma-1 receptor-dependent manner.短链脂肪酸通过 Sigma-1 受体依赖的方式减轻甲基苯丙胺诱导的肝损伤。
Ecotoxicol Environ Saf. 2024 Jul 15;280:116538. doi: 10.1016/j.ecoenv.2024.116538. Epub 2024 Jun 3.
10
The role of sigma 1 receptor in organization of endoplasmic reticulum signaling microdomains.西格玛 1 受体在细胞内质网信号微区组织中的作用。
Elife. 2021 May 11;10:e65192. doi: 10.7554/eLife.65192.
引用本文的文献
1
Association and Interaction of Epstein-Barr Virus with SARS-CoV-2 Infection-A Review.爱泼斯坦-巴尔病毒与严重急性呼吸综合征冠状病毒2感染的关联及相互作用——综述
Viruses. 2025 Jun 26;17(7):903. doi: 10.3390/v17070903.
2
A systematic review and meta-analysis, investigating dose and time of fluvoxamine treatment efficacy for COVID-19 clinical deterioration, death, and Long-COVID complications.一项系统评价和荟萃分析，研究了氟伏沙明治疗 COVID-19 病情恶化、死亡和长期 COVID 并发症的剂量和时间疗效。
Sci Rep. 2024 Jun 12;14(1):13462. doi: 10.1038/s41598-024-64260-9.
3
Detrimental effects of COVID-19 in the brain and therapeutic options for long COVID: The role of Epstein-Barr virus and the gut-brain axis.新冠病毒对大脑的有害影响及新冠长期症状的治疗选择：爱泼斯坦-巴尔病毒和肠-脑轴的作用
Mol Psychiatry. 2023 Dec;28(12):4968-4976. doi: 10.1038/s41380-023-02161-5. Epub 2023 Jul 4.
4
Overview of the potential use of fluvoxamine for COVID-19 and long COVID.氟伏沙明用于治疗新冠病毒病及新冠后综合征的潜在用途概述。
Discov Ment Health. 2023;3(1):9. doi: 10.1007/s44192-023-00036-3. Epub 2023 Mar 21.
5
Arketamine for cognitive impairment in psychiatric disorders.氯胺酮治疗精神障碍的认知障碍。
Eur Arch Psychiatry Clin Neurosci. 2023 Oct;273(7):1513-1525. doi: 10.1007/s00406-023-01570-5. Epub 2023 Feb 14.
6
Selective serotonin reuptake inhibitors: New hope in the fight against COVID-19.选择性5-羟色胺再摄取抑制剂：对抗新冠病毒的新希望。
Front Pharmacol. 2022 Nov 30;13:1036093. doi: 10.3389/fphar.2022.1036093. eCollection 2022.
本文引用的文献
1
Fluvoxamine and long COVID-19; a new role for sigma-1 receptor (S1R) agonists.氟伏沙明与长期新冠；σ-1受体（S1R）激动剂的新作用
Mol Psychiatry. 2022 Sep;27(9):3562. doi: 10.1038/s41380-022-01545-3. Epub 2022 Apr 6.
2
Mechanisms of action of fluvoxamine for COVID-19: a historical review.氟伏沙明治疗 COVID-19 的作用机制：历史回顾。
Mol Psychiatry. 2022 Apr;27(4):1898-1907. doi: 10.1038/s41380-021-01432-3. Epub 2022 Jan 7.
3
Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review.SARS-CoV-2 感染后急性后遗症的短期和长期发生率：系统评价。
JAMA Netw Open. 2021 Oct 1;4(10):e2128568. doi: 10.1001/jamanetworkopen.2021.28568.
4
Old drug fluvoxamine, new hope for COVID-19.老药氟伏沙明，为新冠疫情带来新希望。
Eur Arch Psychiatry Clin Neurosci. 2022 Feb;272(1):161-163. doi: 10.1007/s00406-021-01326-z. Epub 2021 Sep 2.
5
Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation.“长新冠”患病率及其与爱泼斯坦-巴尔病毒再激活关系的调查
Pathogens. 2021 Jun 17;10(6):763. doi: 10.3390/pathogens10060763.
6
Positive Epstein-Barr virus detection in coronavirus disease 2019 (COVID-19) patients.在 2019 冠状病毒病（COVID-19）患者中检测到 EBV 呈阳性。
Sci Rep. 2021 May 25;11(1):10902. doi: 10.1038/s41598-021-90351-y.
7
How COVID-19 Affects the Brain.新冠病毒如何影响大脑。
JAMA Psychiatry. 2021 Jun 1;78(6):682-683. doi: 10.1001/jamapsychiatry.2021.0500.
8
Repurposing of CNS drugs to treat COVID-19 infection: targeting the sigma-1 receptor.重新利用中枢神经系统药物治疗 COVID-19 感染：靶向 sigma-1 受体。
Eur Arch Psychiatry Clin Neurosci. 2021 Mar;271(2):249-258. doi: 10.1007/s00406-020-01231-x. Epub 2021 Jan 5.
9
Modulation of the sigma-1 receptor-IRE1 pathway is beneficial in preclinical models of inflammation and sepsis.调节 sigma-1 受体-IRE1 通路对炎症和脓毒症的临床前模型有益。
Sci Transl Med. 2019 Feb 6;11(478). doi: 10.1126/scitranslmed.aau5266.
10
In vivo intratumoral Epstein-Barr virus replication is associated with XBP1 activation and early-onset post-transplant lymphoproliferative disorders with prognostic implications.体内肿瘤内爱泼斯坦-巴尔病毒复制与XBP1激活以及具有预后意义的移植后早期淋巴增殖性疾病相关。
Mod Pathol. 2014 Dec;27(12):1599-611. doi: 10.1038/modpathol.2014.68. Epub 2014 Apr 25.
Zotero 插件